title: [What strategy for the screening of coronary artery disease in type 1 diabetes?].
abstract: Screening benefits for silent coronary artery disease in type 2 diabetes patients has been recently questioned following the publication of the DIAD study. For type 1 diabetes, there are no specific screening recommendations. For these patients, duration of the disease and microvascular complications are to be taken into account in assessing the risk of coronary artery disease. Intensive glycemic control reduces cardiovascular mortality. Other cardiovascular risk factors are also to be taken into consideration in assessing coronary risk, and should also be treated aggressively. Given the lack of prospective studies evaluating screening benefit for silent coronary artery disease in type 1 diabetes patients, screening strategies should be assessed depending on the context.
authors.affiliation: Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. sophie.comte@chuv.ch
authors.forename: S
authors.initials: S
authors.lastname: Comte-Perret
authors.forename: J
authors.initials: J
authors.lastname: Ruiz
mesh_terms: D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003935:Diagnostic Techniques, Cardiovascular; D006801:Humans; D012307:Risk Factors